TrialBreast cancer research and treatment2026

Efficacy, safety and circulating tumor cell dynamics in patients treated with Eribulin for HER2-negative advanced breast cancer - results from the phase II DETECT IVb trial.

F Schochter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.